Durvalumab vs Sacubitril-Valsartan

## Durvalumab vs Sacubitril-Valsartan: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Sacubitril-Valsartan**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Sacubitril-Valsartan**: Angiotensin receptor-neprilysin inhibitor (ARNI) combining neprilysin inhibition with AT1 receptor blockade.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Sacubitril-Valsartan — 11.5 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Sacubitril-Valsartan — C24H29N2O5.

**Molecular Weight**: Durvalumab — N/A; Sacubitril-Valsartan — 414.5010 g/mol.

**Type**: Durvalumab — Antibody; Sacubitril-Valsartan — Small molecule.